With great power, comes great responsibility

29 November 2013
canberra-big

Australia’s PBS praised while government is called on to protect IP

A survey showed this week that Australians think the country’s Pharmaceutical Benefits Scheme is a good use of taxes. Some 51% of Australian adults take a prescription medicine daily – equivalent to 9 million adult Australians – and 86% of these think the PBS is a good investment of taxpayer dollars. In an age when spending on medicines has never been more debated, the trade group Medicines Australia hailed this as a victory for the industry. The survey also highlighted concerns about delays in accessing new medication, with PBS listings crucial to allow access for most Australians.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight